Examen Ltd

Back to portfolio

In vitro diagnostics company specialising in male infertility and miscarriage testing.

Examen is a diagnostics company. Our mission is to transform the diagnosis and treatment of male reproductive problems. 

Examen was set up in response to public demand for our market–leading sperm DNA fragmentation test, the SpermComet®. SpermComet® was developed following more than twenty years of research into better tests for male infertility and treatment. Now we can provide accurate information for male fertility diagnosis and better prediction of fertility treatment success. The founder of Examen is internationally acclaimed academic in male fertility; Professor Sheena Lewis FRSB.

Key Facts

  • We provide a unique, accurate molecular test that checks out the quality of sperm DNA.
  • High sperm DNA damage causes male infertility
  • High sperm DNA damage leads to poor fertility treatment success
  • High sperm DNA damage causes miscarriage
  • Having the test gives couples new options and saves them time, money and heartbreak
    Visit website
    • Digital, Environmental, Engineering

      Catagen Ltd

      Read more
    • Environmental, Engineering, Scientific

      Porous Liquid Technologies Ltd

      Read more
    • Life Science

      VascVersa Ltd

      We have developed a fast, simple, and consistent method to generate valuable primary human vascular stem cells from a small, easily obtained sample of human umbilical cord blood.

      Read more
    • Life Science

      CV6 Therapeutics (NI) Ltd

      CV6 Therapeutics is dedicated to the development of novel innovative therapeutics to improve the lives of patients with cancer and inflammatory diseases.

      Read more